Emerging molecular targets and therapy for cholangiocarcinoma

被引：0

作者：

Hamzeh Kayhanian ^{[1
]}

Elizabeth C Smyth ^{[1
]}

Chiara Braconi ^{[1
,2
]}

机构：

[1] Department of Gastrointestinal Oncology, Royal Marsden Hospital, London and Surrey SM2 5PT

[2] Institute of Cancer Research, London and Surrey SM2 5PT

来源：

World Journal of Gastrointestinal Oncology | 2017年 / 07期

关键词：

Cholangiocarcinoma; Biliary tract cancer; Targeted therapy; immunotherapy; Mutation; Molecular; Microenvironment; Stroma; MiRNA;

D O I：

暂无

中图分类号：

R735.8 [胆囊、胆道肿瘤];

学科分类号：

100214 ;

摘要：

Cholangiocarcinoma(CCA) is a rare cancer arising from the biliary tree with a poor prognosis and limited therapeutic options. Recent large scale molecular characterisation studies have identified recurrent genetic alterations in CCA which may be amenable to therapeutic targeting. In this review we explore the genomic landscape of CCA and examine results from trials of molecularly targeted agents and immunotherapy in this disease. Challenges in CCA diagnosis, treatment and trial design are discussed and we reflect on future directions which may lead to improved outcomes for CCA patients.

引用

页码：268 / 280

页数：13

共 50 条

[31] Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma
Montal, Robert
Sia, Daniela
Montironi, Carla
Leow, Wei Q.
Esteban-Fabro, Roger
Pinyol, Roser
Torres-Martin, Miguel
Bassaganyas, Laia
Moeini, Agrin
Peix, Judit
Cabellos, Laia
Maeda, Miho
Villacorta-Martin, Carlos
Tabrizian, Parissa
Rodriguez-Carunchio, Leonardo
Castellano, Giancarlo
Sempoux, Christine
Minguez, Beatriz
Pawlik, Timothy M.
Labgaa, Ismail
Roberts, Lewis R.
Sole, Manel
Fiel, Maria, I
Thung, Swan
Fuster, Josep
Roayaie, Sasan
Villanueva, Augusto
Schwartz, Myron
Llovet, Josep M.
JOURNAL OF HEPATOLOGY, 2020, 73 (02) : 315 - 327
[32] Molecular profiling reveals potential targets in cholangiocarcinoma
Dan Liu
Yang Shi
Hongze Chen
Muhammad Azhar Nisar
Nicholas Jabara
Noah Langwinski
Sophia Mattson
Katsuya Nagaoka
Xuewei Bai
Shaolei Lu
Chiung-Kuei Huang
World Journal of Gastroenterology, 2023, (25) : 4053 - 4071
[33] Emerging targets in osteoarthritis therapy
Goldring, Mary B.
Berenbaum, Francis
CURRENT OPINION IN PHARMACOLOGY, 2015, 22 : 51 - 63
[34] Emerging Targets of Diuretic Therapy
Cheng, C-J
Rodan, A. R.
Huang, C-L
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (03) : 420 - 435
[35] Current and Emerging Therapeutic Targets for the Treatment of Cholangiocarcinoma: An Updated Review
Hadfield, Matthew J.
DeCarli, Kathryn
Bash, Kinan
Sun, Grace
Almhanna, Khaldoun
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (01)
[36] The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets
Chong, Dawn Q.
Zhu, Andrew X.
ONCOTARGET, 2016, 7 (29) : 46750 - 46767
[37] Cholangiocarcinoma: An emerging indication for photodynamic therapy Comment
Lecleire, Stephane
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2009, 6 (02) : 93 - 93
[38] Emerging therapeutic targets - Molecular targets for weight control
Gurwitz, D
DRUG DISCOVERY TODAY, 1998, 3 (09) : 426 - 426
[39] Emerging cellular and molecular targets in fibrosis: implications for scleroderma pathogenesis and targeted therapy
Castelino, Flavia V.
Varga, John
CURRENT OPINION IN RHEUMATOLOGY, 2014, 26 (06) : 607 - 614
[40] Molecular Classification and Potential Therapeutic Targets in Extrahepatic Cholangiocarcinoma
Montal, Robert
Leow, Wei-Qiang
Montironi, Carla
Bassaganyas, Laia
Moeini, Agrin
Sia, Daniela
Pinyol, Roser
Peix, Judit
Cabellos, Laia
Maeda, Miho
Villacorta, Carlos
Tabrizian, Parissa
Sempoux, Christine
Minguez, Beatriz
Pawlik, Tim
Labgaa, Ismail
Roberts, Lewis R.
Sole, Manel
Fiel, Maria Isabel
Thung, Swan N.
Roayaie, Sasan
Villanueva, Augusto
Schwartz, Myron E.
Llovet, Josep M.
HEPATOLOGY, 2018, 68 : 18A - 19A

← 1 2 3 4 5 →